Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Amos Katz, Ahmad Masri et al.|The Lancet|2020Cited by 1.2k
Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin AmyloidPablo García‐Pavía, Thibaud Damy, Fabian aus dem Siepen et al.|New England Journal of Medicine|2023Cited by 233